- ARC Group Worldwide, Inc. stock price today and history
ARC Group Worldwide, Inc. (ARCW) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
ARC Group Worldwide, Inc. stock price
ARC Group Worldwide, Inc. latest news:
Exelixis, Ipsen report positive cancer-study results
Exelixis Inc. and Ipsen said Tuesday that a cancer drug achieved its target in a late-stage study and will be submitted to the Food and Drug Administration before the end of the quarter. The companies said that its cabozantinib drug helped patients with advanced hepatocellular carcinoma survive a median 2.2 months longer than patients who received placebos in a phase 3 trial. "Given the worldwide prevalence of advanced hepatocellular carcinoma, there is a continued urgency to bring new treatment options to this patient population," Exelixis Chief Medical Officer Gisela Schwab said in Tuesday's announcement. "We look forward to submitting our supplemental New Drug Application to the FDA for cabozantinib in the first quarter of 2018." The companies plan to present the results at a symposium in San Francisco later this week, and will hold a webcast meant for investors Friday evening. Exelixis shares were halted ahead of the announcement, and gained about 2% in after-hours action after they began trading again at 5:30 p.m. Eastern time.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Arc Group Worldwide Names Brian Knaley As CFO
* ARC GROUP WORLDWIDE INC - ANNOUNCED APPOINTMENT OF R.
KNALEY AS COMPANY'S NEW CHIEF FINANCIAL OFFICER
BRIEF-Stifel, Nicolaus & Co Inc reported passive stake of 5.08 pct in Arc Group Worldwide
Arc Group Worldwide Inc(ARCW): * Stifel, Nicolaus & Company Inc reported passive stake of 5.08 percent in Arc Group Worldwide Inc (ARCW) as on October 31, 2017 - SEC filing Source text Further company coverage:
ARCA biopharma, Inc.ABIO
Arcadia Biosciences, Inc.RKDA
Arch Capital Group Ltd.ACGL
Arctic Cat Inc.ACAT
Arena Pharmaceuticals, Inc.ARNA
Ares Capital CorporationARCC
Argo Group International Holdings, Ltd.AGII
Argo Group International Holdings, Ltd.AGIIL